Botulinum toxin type A by iontophoresis for primary palmar hyperhidrosis

Journal of the American Academy of Dermatology

Volumn 55, Issue 5 SUPPL., 2006, Pages

  Kavanagh, Gina M ^a   Shams, Kave ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAVIMETRY; HUMAN; HYPERHIDROSIS; INJECTION SITE PAIN; IONTOPHORESIS; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STUDENT T TEST; SWEATING; TREATMENT RESPONSE;

ADULT; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS, TYPE A; DOUBLE-BLIND METHOD; FEMALE; HAND; HUMANS; HYPERHIDROSIS; IONTOPHORESIS; MALE; NEUROMUSCULAR AGENTS; TREATMENT OUTCOME;

EID: 33749656593     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.07.017     Document Type: Article

References (11)

1. Baumgartner F., and Toh Y. Severe hyperhidrosis: clinical features and current thoracoscopic surgical management. Ann Thorac Surg 76 (2003) 1878-1883
2. Lowe N., Yamauchi P., Lask G., Patnaik R., and Iver S. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg 28 (2002) 822-827
3. Simonetta M., Cauhepe C., Magues J., and Senard J. A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis. Br J Dermatol 149 (2003) 1041-1045
4. Pikal M. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev 46 (2001) 281-305
5. Zempsky W., and Parkinson T. Lidocaine iontophoresis for topical anesthesia before dermatologic procedures in children: a randomized controlled trial. Pediatr Dermatol 20 (2003) 364-368
6. Prausnitz M., Mitragotri S., and Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Dis 3 (2004) 115-124
7. Manabe E., Numajiri S., Sugibayashi K., and Morimoto Y. Analysis of skin permeation-enhancing mechanism of iontophoresis using hydrodynamic pore theory. J Control Release 66 (2000) 149-158
8. Chen F., Kuziemko G.M., and Stevens R.C. Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species. Infect Immun 66 (1998) 2420-2425
9. Kavanagh G., and Shams K. Case report: BOTOX iontophoresis. Br J Dermatol 151 (2004) 1093-1095
10. Schnider P., Moraru E., Kittler H., Binder M., Kranz G., and Voller B. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients. Br J Dermatol 145 (2001) 289-293
11. Coleman M.K. Botulinum toxin in facial rejuvenation (2004), Mosby, London p. 22